CNO — California Nanotechnologies Balance Sheet
0.000.00%
- CA$19.81m
- CA$20.94m
- $2.79m
Annual balance sheet for California Nanotechnologies, fiscal year end - February 28th, USD millions except per share, conversion factor applied.
2022 February 28th | 2023 February 28th | 2024 February 29th | 2025 February 28th | 2026 February 28th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.051 | 0.216 | 0.841 | 0.534 | 0.207 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.351 | 0.176 | 0.433 | 1.23 | 0.57 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.406 | 0.54 | 1.99 | 1.83 | 0.857 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.549 | 0.493 | 0.362 | 3.63 | 2.98 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.959 | 1.04 | 2.36 | 5.5 | 3.88 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.78 | 1.76 | 1.03 | 1.88 | 0.919 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.03 | 1.98 | 2.21 | 3.19 | 1.9 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -1.07 | -0.947 | 0.146 | 2.32 | 1.98 |
| Total Liabilities & Shareholders' Equity | 0.959 | 1.04 | 2.36 | 5.5 | 3.88 |
| Total Common Shares Outstanding |